Search research articles
Contact Us
Filters
Showing results (51-60 of 117) with videos related to
Page
of 12
Sort By:
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
December 5, 2022
Long-term effects of eliglustat on skeletal manifestations in clinical trials of patients with Gaucher disease type 1
Timothy M Cox, Joel Charrow, Elena Lukina, et al.
The Cochrane Database of Systematic Reviews
|
March 28, 2015
Enzyme replacement and substrate reduction therapy for Gaucher disease
Elad Shemesh, Laura Deroma, Bruno Bembi, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
August 31, 2006
TRACP Influences Th1 pathways by affecting dendritic cell function
Ehsanollah Esfandiari, Michael Bailey, Christopher R Stokes, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 28, 2006
Effective gene therapy in an authentic model of Tay-Sachs-related diseases
M Begoña Cachón-González, Susan Z Wang, Andrew Lynch, et al.
Journal of Neurology
|
May 31, 2018
The motor and cognitive features of Parkinson's disease in patients with concurrent Gaucher disease over 2 years: a case series
Lucy M Collins, Caroline H Williams-Gray, Elizabeth Morris, et al.
Calcified Tissue International
|
June 7, 2007
Altered collagen in tartrate-resistant acid phosphatase (TRAP)-deficient mice: a role for TRAP in bone collagen metabolism
Helen C Roberts, Lynda Knott, Nicholas C Avery, et al.
Skeletal Radiology
|
August 1, 2020
Improving the quantitative classification of Erlenmeyer flask deformities
Gautam Adusumilli, Joshua D Kaggie, Simona D'Amore, et al.
Orphanet Journal of Rare Diseases
|
December 29, 2012
Evaluation of miglustat as maintenance therapy after enzyme therapy in adults with stable type 1 Gaucher disease: a prospective, open-label non-inferiority study
Timothy M Cox, Dominick Amato, Carla Em Hollak, et al.
The Journal of Pathology
|
September 27, 2014
Inhibition of UDP-glucosylceramide synthase in mice prevents Gaucher disease-associated B-cell malignancy
Elena V Pavlova, Joy Archer, Susan Wang, et al.
Plos Genetics
|
October 3, 2012
Characterization of inducible models of Tay-Sachs and related disease
Timothy J Sargeant, Deborah J Drage, Susan Wang, et al.
Page
of 12
Search research articles
Search
Showing results (51-60 of 117) with videos related to
Sort By:
Page
of 12
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
December 5, 2022
Long-term effects of eliglustat on skeletal manifestations in clinical trials of patients with Gaucher disease type 1
Timothy M Cox, Joel Charrow, Elena Lukina, et al.
The Cochrane Database of Systematic Reviews
|
March 28, 2015
Enzyme replacement and substrate reduction therapy for Gaucher disease
Elad Shemesh, Laura Deroma, Bruno Bembi, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
August 31, 2006
TRACP Influences Th1 pathways by affecting dendritic cell function
Ehsanollah Esfandiari, Michael Bailey, Christopher R Stokes, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 28, 2006
Effective gene therapy in an authentic model of Tay-Sachs-related diseases
M Begoña Cachón-González, Susan Z Wang, Andrew Lynch, et al.
Journal of Neurology
|
May 31, 2018
The motor and cognitive features of Parkinson's disease in patients with concurrent Gaucher disease over 2 years: a case series
Lucy M Collins, Caroline H Williams-Gray, Elizabeth Morris, et al.
Calcified Tissue International
|
June 7, 2007
Altered collagen in tartrate-resistant acid phosphatase (TRAP)-deficient mice: a role for TRAP in bone collagen metabolism
Helen C Roberts, Lynda Knott, Nicholas C Avery, et al.
Skeletal Radiology
|
August 1, 2020
Improving the quantitative classification of Erlenmeyer flask deformities
Gautam Adusumilli, Joshua D Kaggie, Simona D'Amore, et al.
Orphanet Journal of Rare Diseases
|
December 29, 2012
Evaluation of miglustat as maintenance therapy after enzyme therapy in adults with stable type 1 Gaucher disease: a prospective, open-label non-inferiority study
Timothy M Cox, Dominick Amato, Carla Em Hollak, et al.
The Journal of Pathology
|
September 27, 2014
Inhibition of UDP-glucosylceramide synthase in mice prevents Gaucher disease-associated B-cell malignancy
Elena V Pavlova, Joy Archer, Susan Wang, et al.
Plos Genetics
|
October 3, 2012
Characterization of inducible models of Tay-Sachs and related disease
Timothy J Sargeant, Deborah J Drage, Susan Wang, et al.
Page
of 12